WT p53 upregulates the expression levels of ULBP1 and ULBP2, members of the ligand of the NKG2D (NKG2DL) family, on the surface of tumor cells and enhances the NK cell-mediated antitumor immune response [51]. The gene discussed is KLRK1; the disease is neoplasm.